Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Vertex Pharmaceuticals Incorporated

NASDAQ: VRTXHealthcare / Biotechnology / USA
194.70+4.18+2.19%Vol 2 119 3071Y Perf 23.59%
Jan 18th, 2019 16:00
BID189.50 ASK195.00
Open192.63 Previous Close190.52
Pre-Market192.33 After-Trading195.00
 1.81 0.95%  0.30 0.15%
Target Price
203.16 
Analyst Rating
Strong Buy 1.45
Potencial %
4.35 
Finscreener Ranking
★★★★+     56.64
Insiders Trans % 3/6/12M
-100/-100/-100 
Value Ranking
★★★+     54.41
Insiders Value % 3/6/12M
-100/-100/-100 
Growth Ranking
★★★★★     79.78
Insiders Shares Cnt. % 3/6/12M
-100/-100/-100 
Income Ranking
 —    -
Market Cap (mil)49 757 
Earnings Rating
Sell
Price Range Ratio 52wk %
99.57 
Earnings Date
30th Jan 2019

Today's Price Range

189.41194.78

 

52wk Range

144.07194.92

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
22.72%
3 Months
10.82%
6 Months
8.09%
1 Year
23.59%
3 Years
104.97%
5 Years
137.18%

Quotes

Name / TickerPriceChg.Chg.%
VRTX194.704.18002.19
AAPL156.820.96000.62
GOOG1 098.268.36000.77
MSFT107.711.59001.50
XOM72.990.86001.19
WFC50.010.78001.58
JNJ130.691.60001.24
FB150.041.74001.17
GE9.06-0.0800-0.88
JPM104.591.67001.62
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
3.50
Current Ratio
3.70
Long Term Debt to Total Capital
0.17
Total Debt to Equity
0.20
Interest Coverage
17.20
Leverage Ratio 1.60
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
86.90
EBIT Margin
22.40
EBITDA Margin
24.90
Pre-tax Profit Margin
-37.20
Profit Margin
25.90
ValuationValueIndustryS&P 500US Markets
PE Ratio
75.00
PB Ratio
16.55
PS Ratios
22.16
Price to Cash Flow
41.10
Price to Free Cash Flow
54.90
Cash Flow Per Share
4.58
Price to Tangible Book
17.01
Book Value per Share
11.37
Enterprise Value (in ths.)
45 618 000
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-26.30
ROE last 12 Months
27.54
Return on Assets (5Y Avg)
-8.13
ROA last 12 Months
16.54
Return on Capital (5Y Avg)
-10.57
ROC last 12 Months
22.03
Return on invested Capital Q
3.80
Return on invested Capital Y
11.36
Assets Turnover
0.20
Receivables Turnover
2.90
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
2 170 150
Revenue per Share
8.49
Revenue Growth 3 Years
29.03
Revenue Growth 5 Years
29.26
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 20180.690.7610.14
Q02 20180.400.6255.00
Q01 20180.280.5492.86
Q04 20170.290.3210.34
Q03 20170.040.24500.00
Q02 20170.060.1066.67
Q01 20170.040.13225.00
Q04 2016-0.010.131 400.00
Earnings Per EndEstimateRevision %Trend
12/2018 QR0.72-2.70Negative
12/2018 FY2.551.59Positive
3/2019 QR0.70-10.26Negative
12/2019 FY3.342.77Positive
Next Report Date30th Jan 2019
Estimated EPS Next Report0.72
Estimates Count8
EPS Growth Next 5 Years %39.50
Volume Overview
Volume2 119 307
Shares Outstanding (in ths.)255 558
Trades Count9 826
Dollar Volume337 813 722
Avg. Volume1 814 662
Avg. Weekly Volume1 820 542
Avg. Monthly Volume1 755 245
Avg. Quarterly Volume1 590 895

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

45%55%

Bearish Bullish

58%43%

Bearish Bullish

58%43%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
15 (71.43 %)
15 (71.43 %)
14 (70.00 %)
Moderate Buy
2 (9.52 %)
3 (14.29 %)
3 (15.00 %)
Hold
4 (19.05 %)
3 (14.29 %)
3 (15.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.45
Strong Buy
1.40
Strong Buy
1.42

There are no comments yet.

News